FDA.reportPublic FDA data

aripiprazole 300 MG extended release Prefilled Syringe

RxCUI
1602163
RxNorm name
aripiprazole 300 MG extended release Prefilled Syringe
Display name
aripiprazole 300 MG extended release Prefilled Syringe
Full name
aripiprazole 300 MG extended release Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ABILIFY MAINTENAARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.ee49f3b1-1650-47ff-9fb1-ea53fe0b92b62026-03-24Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1602163

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ee49f3b1-1650-47ff-9fb1-ea53fe0b92b6ARIPiprazole 300 MG Extended Release Prefilled Syringe [PSN] · 1.5 ML aripiprazole 200 MG/ML Prefilled Syringe [SCD] · aripiprazole 300 MG extended release Prefilled Syringe [SY] · aripiprazole 300 MG per 1.5 ML extended release Prefilled Syringe [SY]427These highlights do not include all the information needed to use ABILIFY MAINTENA safely and effectively. See full prescribing information for ABILIFY MAINTENA. ABILIFY MAINTENA ® (aripiprazole) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 200220260324